In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control-Reference-Cited by-同舟云学术

In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control

Published:2018-09 Issue:9 Volume:14 Page:1233-1239
ISSN:1550-7289
Container-title:Surgery for Obesity and Related Diseases
language:en
Short-container-title:Surgery for Obesity and Related Diseases

Author:

Schwenger Katherine J.P.^ORCID,Fischer Sandra E.,Jackson Timothy,Okrainec Allan,Allard Johane P.

Publisher

Elsevier BV

Subject

Surgery

Reference32 articles.

1. Hepatic histology in obese patients undergoing bariatric surgery;Machado;J Hepatol,2006

2. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome;Marchesini;Hepatology,2003

3. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Review;J Clin Gastroenterol,2014

4. Clinical approaches to non-alcoholic fatty liver disease;Schwenger;World J Gastroenterol,2014

5. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012;Chang;JAMA Surg,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Links between fecal microplastics and parameters related to metabolic dysfunction-associated steatotic liver disease (MASLD) in humans: An exploratory study;Science of The Total Environment;2024-11

2. Assessing clinical and metabolic responses related to hyperlipidemia, MASLD and type 2 diabetes: sleeve versus RYGB;Nutrition;2024-10

3. Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery;Trends in Endocrinology & Metabolism;2024-06

4. Gut microbiome modified by bariatric surgery improves insulin sensitivity and correlates with increased brown fat activity and energy expenditure;Cell Reports Medicine;2023-05

5. Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes;Metabolites;2023-04-04